Works matching DE "TEMOZOLOMIDE"


Results: 1726
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 148, n. 3, p. 607, doi. 10.1007/s11060-020-03558-w
    By:
    • Crotty, Erin E.;
    • Leary, Sarah E. S.;
    • Geyer, J. Russell;
    • Olson, James M.;
    • Millard, Nathan E.;
    • Sato, Aimee A.;
    • Ermoian, Ralph P.;
    • Cole, Bonnie L.;
    • Lockwood, Christina M.;
    • Paulson, Vera A.;
    • Browd, Samuel R.;
    • Ellenbogen, Richard G.;
    • Hauptman, Jason S.;
    • Lee, Amy;
    • Ojemann, Jeffrey G.;
    • Vitanza, Nicholas A.
    Publication type:
    Article
    10
    11

    Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 148, n. 1, p. 17, doi. 10.1007/s11060-020-03505-9
    By:
    • Natsume, Atsushi;
    • Aoki, Kosuke;
    • Ohka, Fumiharu;
    • Maeda, Sachi;
    • Hirano, Masaki;
    • Adilijiang, Alimu;
    • Motomura, Kazuya;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko
    Publication type:
    Article
    12

    Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 147, n. 3, p. 653, doi. 10.1007/s11060-020-03466-z
    By:
    • Song, Andrew;
    • Bar-Ad, Voichita;
    • Martinez, Nina;
    • Glass, Jon;
    • Andrews, David W.;
    • Judy, Kevin;
    • Evans, James J.;
    • Farrell, Christopher J.;
    • Werner-Wasik, Maria;
    • Chervoneva, Inna;
    • Ly, Michele;
    • Palmer, Joshua D.;
    • Liu, Haisong;
    • Shi, Wenyin
    Publication type:
    Article
    13

    Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 147, n. 2, p. 297, doi. 10.1007/s11060-020-03451-6
    By:
    • Marenco-Hillembrand, Lina;
    • Wijesekera, Olindi;
    • Suarez-Meade, Paola;
    • Mampre, David;
    • Jackson, Christina;
    • Peterson, Jennifer;
    • Trifiletti, Daniel;
    • Hammack, Julie;
    • Ortiz, Kyle;
    • Lesser, Elizabeth;
    • Spiegel, Matthew;
    • Prevatt, Calder;
    • Hawayek, Maria;
    • Quinones-Hinojosa, Alfredo;
    • Chaichana, Kaisorn L.
    Publication type:
    Article
    14
    15
    16

    Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.

    Published in:
    Journal of Neuro-Oncology, 2020, v. 146, n. 2, p. 239, doi. 10.1007/s11060-019-03365-y
    By:
    • Bikhezar, Fatima;
    • de Kruijff, Robin M.;
    • van der Meer, Astrid J. G. M.;
    • Torrelo Villa, Guzman;
    • van der Pol, Susanne M. A.;
    • Becerril Aragon, Gabriel;
    • Gasol Garcia, Ana;
    • Narayan, Ravi S.;
    • de Vries, Helga E.;
    • Slotman, Ben J.;
    • Denkova, Antonia G.;
    • Sminia, Peter
    Publication type:
    Article
    17
    18
    19
    20

    Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 145, n. 1, p. 115, doi. 10.1007/s11060-019-03277-x
    By:
    • Rudà, Roberta;
    • Pellerino, Alessia;
    • Pace, Andrea;
    • Carapella, Carmine Maria;
    • Dealis, Cristina;
    • Caroli, Manuela;
    • Faedi, Marina;
    • Bello, Lorenzo;
    • Migliore, Enrica;
    • Marchese, Giulia;
    • Bertero, Luca;
    • Cassoni, Paola;
    • Soffietti, Riccardo
    Publication type:
    Article
    21
    22
    23

    Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 447, doi. 10.1007/s11060-019-03175-2
    By:
    • Pedretti, Sara;
    • Masini, Laura;
    • Turco, Enrico;
    • Triggiani, Luca;
    • Krengli, Marco;
    • Meduri, Bruno;
    • Pirtoli, Luigi;
    • Borghetti, Paolo;
    • Pegurri, Ludovica;
    • Riva, Nada;
    • Gatta, Roberto;
    • Fusco, Vincenzo;
    • Scoccianti, Silvia;
    • Bruni, Alessio;
    • Ricardi, Umberto;
    • Santoni, Riccardo;
    • Magrini, Stefano M.;
    • Buglione, Michela
    Publication type:
    Article
    24
    25
    26

    Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 1, p. 91, doi. 10.1007/s11060-018-03065-z
    By:
    • Fabbro-Peray, Pascale;
    • Zouaoui, Sonia;
    • Darlix, Amélie;
    • Fabbro, Michel;
    • Pallud, Johan;
    • Rigau, Valérie;
    • Mathieu-Daude, Hélène;
    • Bessaoud, Faiza;
    • Bauchet, Fabienne;
    • Riondel, Adeline;
    • Sorbets, Elodie;
    • Charissoux, Marie;
    • Amelot, Aymeric;
    • Mandonnet, Emmanuel;
    • Figarella-Branger, Dominique;
    • Duffau, Hugues;
    • Tretarre, Brigitte;
    • Taillandier, Luc;
    • Bauchet, Luc
    Publication type:
    Article
    27

    Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 1, p. 59, doi. 10.1007/s11060-018-03059-x
    By:
    • Navarria, Pierina;
    • Minniti, Giuseppe;
    • Clerici, Elena;
    • Tomatis, Stefano;
    • Pinzi, Valentina;
    • Ciammella, Patrizia;
    • Galaverni, Marco;
    • Amelio, Dante;
    • Scartoni, Daniele;
    • Scoccianti, Silvia;
    • Krengli, Marco;
    • Masini, Laura;
    • Draghini, Lorena;
    • Maranzano, Ernesto;
    • Borzillo, Valentina;
    • Muto, Paolo;
    • Ferrarese, Fabio;
    • Fariselli, Laura;
    • Livi, Lorenzo;
    • Pasqualetti, Francesco
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 139, n. 2, p. 323, doi. 10.1007/s11060-018-2894-5
    By:
    • Fujihara, Toshitaka;
    • Mizobuchi, Yoshifumi;
    • Nakajima, Kohei;
    • Kageji, Teruyoshi;
    • Matsuzaki, Kazuhito;
    • Kitazato, Keiko T.;
    • Otsuka, Ryotaro;
    • Hara, Keijiro;
    • Mure, Hideo;
    • Okazaki, Toshiyuki;
    • Kuwayama, Kazuyuki;
    • Nagahiro, Shinji;
    • Takagi, Yasushi
    Publication type:
    Article
    36
    37

    Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 667, doi. 10.1007/s11060-018-2839-z
    By:
    • Koo, Taeryool;
    • Lim, Do Hoon;
    • Seol, Ho Jun;
    • Park, Chul-Kee;
    • Kim, Il Han;
    • Chang, Jong Hee;
    • Lee, Jeongshim;
    • Jung, Shin;
    • Gwak, Ho-Shin;
    • Cho, Kwan Ho;
    • Hong, Chang-Ki;
    • Lee, Ik Jae;
    • Kim, El;
    • Kim, Jin Hee;
    • Hong, Yong-Kil;
    • Jang, Hong Seok;
    • Kim, Chae-Yong;
    • Kim, In Ah;
    • Kim, Sung Hwan;
    • Kim, Young Il
    Publication type:
    Article
    38
    39

    JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 627, doi. 10.1007/s11060-018-2831-7
    By:
    • Wakabayashi, Toshihiko;
    • Natsume, Atsushi;
    • Mizusawa, Junki;
    • Katayama, Hiroshi;
    • Fukuda, Haruhiko;
    • Sumi, Minako;
    • Nishikawa, Ryo;
    • Narita, Yoshitaka;
    • Muragaki, Yoshihiro;
    • Maruyama, Takashi;
    • Ito, Tamio;
    • Beppu, Takaaki;
    • Nakamura, Hideo;
    • Kayama, Takamasa;
    • Sato, Shinya;
    • Nagane, Motoo;
    • Mishima, Kazuhiko;
    • Nakasu, Yoko;
    • Kurisu, Kaoru;
    • Yamasaki, Fumiyuki
    Publication type:
    Article
    40
    41

    ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 479, doi. 10.1007/s11060-018-2819-3
    By:
    • Dréan, Antonin;
    • Rosenberg, Shai;
    • Lejeune, François-Xavier;
    • Goli, Larissa;
    • Nadaradjane, Aravindan Arun;
    • Guehennec, Jérémy;
    • Schmitt, Charlotte;
    • Verreault, Maïté;
    • Bielle, Franck;
    • Mokhtari, Karima;
    • Sanson, Marc;
    • Carpentier, Alexandre;
    • Delattre, Jean-Yves;
    • Idbaih, Ahmed
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49

    Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 273, doi. 10.1007/s11060-017-2649-8
    By:
    • Sage, William;
    • Guilfoyle, Mathew;
    • Luney, Catriona;
    • Young, Adam;
    • Sinha, Rohitashwa;
    • Sgubin, Donatella;
    • McAbee, Joseph H.;
    • Ma, Ruichong;
    • Jefferies, Sarah;
    • Jena, Rajesh;
    • Harris, Fiona;
    • Allinson, Kieren;
    • Matys, Tomasz;
    • Qian, Wendi;
    • Santarius, Thomas;
    • Price, Stephen;
    • Watts, Colin
    Publication type:
    Article
    50

    Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma.

    Published in:
    Journal of Neuro-Oncology, 2017, v. 135, n. 3, p. 545, doi. 10.1007/s11060-017-2601-y
    By:
    • Zhu, Jay-Jiguang;
    • Demireva, Petya;
    • Kanner, Andrew;
    • Pannullo, Susan;
    • Mehdorn, Maximilian;
    • Avgeropoulos, Nicholas;
    • Salmaggi, Andrea;
    • Silvani, Antonio;
    • Goldlust, Samuel;
    • David, Carlos;
    • Benouaich-Amiel, Alexandra
    Publication type:
    Article